Heart and Muscle Health

18 biomarkers Peer-reviewed

Biomarkers in this category

18 biomarkers · optimal ranges shown

Asymmetric dimethylarginine

found mostly in brain tissue and raised in brain injury

found mostly in the heart muscle and raised in myocardial infarction

found mostly in skeletal muscles and raised in muscular injuries

Muscle enzyme measuring tissue damage in heart, skeletal muscle, or brain.

Aiding in the prognosis for people diagnosed with heart failure

The relative index represents the ratio of CKMB to the CK, total. Relative index = CK-MB, in ng/mL ÷ CK, total, U/L x 100. Due to the different units measured (ng/mL for CK-MB vs. U/L for CK, total), this does not represent a true percentage and is, therefore, called a “relative index.” Currently, a relative index of ≥5.0% suggests the MB may be myocardial in origin. The relative index may be of particular value in patients who have an elevated CK, total due to trauma or surgery. Both an elevated CK-MB and Relative Index are suggestive of Myocardial Infarction.

released in response to changes in pressure inside the heart.

NT-proBNP
Serum Plasma

released in response to changes in pressure inside the heart.

ADMA/SDMA may be measured in individuals with multiple risk factors for the development of CVD. SDMA is primarily excreted in the urine and identifies reduced renal function. One of the earliest manifestations of endothelial dysfunction is nitric oxide (NO) deficiency, which promotes atherosclerosis. Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), its structural isomer, are metabolites of L-arginine, an amino acid that is catalyzed to L-citrulline and NO by nitric oxide synthase (NOS). Both ADMA and SDMA have distinct pathophysiologies and manifestations. ADMA is a competitive inhibitor of NOS thereby reducing NO production and promoting endothelial dysfunction. SDMA also interferes with NO production, but does so indirectly by reducing the cellular availability of arginine. ADMA is primarily cleared through enzymatic degradation in the bloodstream and its presence identifies subclinical cardiovascular disease (CVD). Conversely, SDMA is primarily excreted in the urine and identifies reduced renal function. Interpretation: ADMA: Low // SDMA: Low Normal endothelial function Med High Low ADMA: Med / High // SDMA: Low Endothelial dysfunction and possible presence of pre-diabetes/diabetes or CVD ADMA: Low // SDMA: High Reduced renal function ADMA: Med / High // SDMA: High - Endothelial dysfunction and possible presence of pre-diabetes/diabetes or CVD - Reduced renal function References: American Diabetes Association Professional Practice Committee; 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S125–S143. https://doi.org/10.2337/dc22-S009

Troponin proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.